Protropin

Active Ingredient(s): Somatrem, Recombinant, rh-GH
FDA Approved: * October 17, 1985
Pharm Company: * GENENTECH
Category: Growth Hormone Treatment

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Protropin Overview

Somatrem is an analogue of growth hormone (GH). Somatrem is a recombinant human growth hormone used for the treatment of short stature due to decreased or absent secretion of endogenous growth hormone. Somatrem was first marketed under the brand name Protropin by Genentech in 1985[1]. It differs from endogenous growth hormone by the addition of an extra methionine at the N-terminus[2][circular reference]. Somatrem has largely been replaced by s...

Read more Protropin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Somatrem

Recent Protropin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Somatrem, Recombinant, rh-GH
  • Injection: 10mg, 10mg/vial, 5mg, 5mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Somatrem, Recombinant, rh-GH or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA